GlassScriptPhysician profile
Lisa M Miracle
NPI 1568972156
$2,395.58
in general payments reported to CMS, 2019-2025
33 companies · $530 in 2025
The $530 reported for 2025 was more than what 87% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $299 · 2022: $340 · 2023: $577 · 2024: $649 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,672 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.76 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $517.65 | 2023-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $263.59 | 2023-2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $183.11 | 2021-2022 | |
| Abbvie INC. | $158.09 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $126.99 | 2025 | Fanapt |
| Aspira Women'S Health INC | $93.12 | 2022 | |
| Myovant Sciences INC. | $91.38 | 2021 | |
| Sage Therapeutics, LLC | $89.97 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $81.06 | 2021-2025 | Slynd |
| Agile Therapeutics, INC. | $75.27 | 2021-2024 | Twirla |
| Organon LLC | $70.18 | 2024-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $58.45 | 2023-2025 | |
| Corcept Therapeutics | $56.07 | 2024 | Korlym |
| Collegium Pharmaceutical, INC. | $52.29 | 2025 | Jornay Pm |
| Sumitomo Pharma America, INC. | $44.15 | 2024-2025 | Myfembree |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $39.05 | 2022 | |
| Novo Nordisk INC | $34.10 | 2022-2023 | Saxenda, Wegovy |
| Janssen Pharmaceuticals, INC | $32.45 | 2025 | Spravato |
| Coopersurgical, INC. | $31.73 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $31.56 | 2025 | Uzedy |
| Hologic Sales and Service, LLC | $31.33 | 2021-2025 | Aptima |
| Alkermes, INC. | $29.85 | 2024 | Vivitrol |
| Otsuka America Pharmaceutical, INC. | $29.19 | 2024 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $24.85 | 2021 | |
| Dexcom, INC. | $22.68 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $20.44 | 2022 | |
| Daiichi Sankyo INC. | $19.83 | 2024 | Injectafer |
| Pfizer INC. | $16.29 | 2024 | |
| Mylan Specialty L.P. | $15.70 | 2023 | Yupelri |
| Merck Sharp & Dohme LLC | $14.36 | 2025 | Rotateq, Capvaxive, Enflonsia |
| Nestle Healthcare Nutrition INC. | $13.68 | 2023 | |
| Lilly USA, LLC | $13.60 | 2022 | |
| Lupin INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Miracle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.